Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Featuring perspectives from Dr Hope S Rugo and Dr Sara M Tolaney, including the following topics:

Introduction: Long-Term Outcomes with Antibody-Drug Conjugates (0:00)

HER2-Positive Breast Cancer (8:02)

HER2-Negative Breast Cancer (32:41)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.